BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palantir
PLTR
|
+$926M |
| 2 |
Sea Limited
SE
|
+$712M |
| 3 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$697M |
| 4 |
Wells Fargo
WFC
|
+$687M |
| 5 |
Blackstone
BX
|
+$652M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$16.4B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.4B |
| 3 |
Apple
AAPL
|
+$3.41B |
| 4 |
Microsoft
MSFT
|
+$3.3B |
| 5 |
Linde
LIN
|
+$2.07B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.52% |
| 2 | Healthcare | 13.51% |
| 3 | Financials | 13.07% |
| 4 | Consumer Discretionary | 11.27% |
| 5 | Communication Services | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Verizon
VZ
$193B
| $16.6B | 0.46% |
296,422,418
-8,948,031
| -3% | -$514M |
|
|
27
iShares Core MSCI Total International Stock ETF
IXUS
$58.4B
| $16B | 0.44% |
218,067,751
+9,520,878
| +5% | +$697M |
|
28
Pfizer
PFE
$142B
| $15.9B | 0.44% |
407,048,272
+1,314,302
| +0.3% | +$51.1M |
|
29
Abbott
ABT
$183B
| $15.3B | 0.43% |
132,190,774
-1,883,532
| -1% | -$220M |
|
30
Salesforce
CRM
$148B
| $14.9B | 0.41% |
60,984,878
-4,098,724
| -6% | -$945M |
|
31
PepsiCo
PEP
$191B
| $14.8B | 0.41% |
100,077,295
-179,347
| -0.2% | -$26.1M |
|
32
AT&T
T
$159B
| $14.6B | 0.41% |
673,718,747
+22,155,949
| +3% | +$504M |
|
33
Merck
MRK
$321B
| $14.6B | 0.41% |
187,155,493
-16,081,481
| -8% | -$1.2B |
|
34
Thermo Fisher Scientific
TMO
$214B
| $14.5B | 0.4% |
28,754,142
-557,677
| -2% | -$263M |
|
35
Coca-Cola
KO
$381B
| $14.5B | 0.4% |
267,092,781
-15,158,896
| -5% | -$825M |
|
36
Netflix
NFLX
$305B
| $14.4B | 0.4% |
272,425,790
-15,645,690
| -5% | -$800M |
|
37
Chevron
CVX
$383B
| $14.3B | 0.4% |
136,355,706
+4,339,477
| +3% | +$458M |
|
|
38
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$784B
| $14.2B | 0.4% |
33,235,000
+8,856,900
| +36% | +$3.7B |
|
39
Eli Lilly
LLY
$1.03T
| $14B | 0.39% |
60,927,657
+1,856,395
| +3% | +$373M |
|
40
Nike
NKE
$62.7B
| $13.9B | 0.39% |
89,911,057
-4,725,845
| -5% | -$636M |
|
41
AbbVie
ABBV
$455B
| $13.8B | 0.38% |
122,591,994
-4,024,003
| -3% | -$453M |
|
42
Texas Instruments
TXN
$255B
| $13.7B | 0.38% |
71,027,719
+58,668
| +0.1% | +$11M |
|
43
Accenture
ACN
$99.9B
| $13.6B | 0.38% |
46,031,720
-2,197,788
| -5% | -$629M |
|
|
44
Wells Fargo
WFC
$258B
| $13.5B | 0.38% |
298,989,029
+15,384,776
| +5% | +$687M |
|
45
Medtronic
MDT
$110B
| $13B | 0.36% |
104,616,309
-2,138,321
| -2% | -$268M |
|
46
Broadcom
AVGO
$1.85T
| $12.9B | 0.36% |
270,456,950
-2,250,750
| -0.8% | -$104M |
|
47
Walmart Inc
WMT
$884B
| $12.7B | 0.35% |
270,185,559
+6,616,314
| +3% | +$308M |
|
48
Danaher
DHR
$138B
| $11.9B | 0.33% |
49,926,223
-1,268,331
| -2% | -$281M |
|
49
Costco
COST
$423B
| $11.9B | 0.33% |
29,955,779
+229,495
| +0.8% | +$86.8M |
|
50
McDonald's
MCD
$191B
| $11.7B | 0.33% |
50,798,802
-663,790
| -1% | -$154M |
|
Similar funds
BlackRock's Q2 2021 Portfolio in Review
As of Q2 2021, BlackRock held 5,668 positions worth $3.59T, up 5.6% from $3.4T the previous quarter. Its ten largest holdings account for 18% of the portfolio.
BlackRock's Q2 2021 filing shows 333 new, 2,001 increased, 2,748 reduced and 150 closed positions. Its largest new stake was Organon & Co: 16,503,495 shares worth $499M. The largest sale was Alibaba, an estimated $16.4B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q2 2021 buy was Organon & Co: 16,503,495 shares worth $499M.
- BlackRock added most to Palantir in Q2 2021, an estimated $926M increase.
- BlackRock's biggest Q2 2021 reduction was Alibaba, cutting an estimated $16.4B.
- BlackRock fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $1.35B.
- BlackRock's ten largest holdings make up 18% of its $3.59T portfolio in Q2 2021.
- BlackRock opened 333 new positions and closed 150 in Q2 2021.
- BlackRock's portfolio value rose 5.6% quarter-over-quarter to $3.59T.
Based on BlackRock's 13F filing for Q2 2021, filed 11 Aug 2021.